Evidence map›Paper›PMID 28405767›Full record

ArticleJournal of gastroenterology2017

Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis.

Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, Toshifumi Hibi, Shiro Nakamura, Andreas Lazar, Anne Martin Robinson, Martha Skup, Nael Mohamed Mostafa, Bidan Huang and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Yasuo SuzukiToho University Medical Center Sakura Hospital, Chiba, Japan.
Satoshi MotoyaIBD Center, Sapporo Kosei General Hospital, Sapporo, Japan.
Hiroyuki HanaiHamamatsu South Hospital, Shizuoka, Japan.
Toshifumi HibiIBD Centre, Kitasato University, Kitasato Institute Hospital, Tokyo, Japan. thibi@insti.kitasato-u.ac.jp.
Shiro NakamuraHyogo College of Medicine Hospital, Nishinomiya, Hyogo, Japan.
Andreas LazarAbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
Anne Martin RobinsonAbbVie, Inc., North Chicago, IL, USA.
Martha SkupAbbVie, Inc., North Chicago, IL, USA.
Nael Mohamed MostafaAbbVie, Inc., North Chicago, IL, USA.
Bidan HuangAbbVie, Inc., North Chicago, IL, USA.
Roopal ThakkarAbbVie, Inc., North Chicago, IL, USA.
Mamoru WatanabeDepartment of Gastroenterology, Tokyo Medical and Dental University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28405767
PMCPMC6828248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.